Penumbra Inc Q4 2020 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst : Great. The first question that we -- just on the -- you gave us some color on cadence and guidance. Considering the quarter and if you back out the onetime charges, your annual 2021 guidance is below just fourth quarter '20 annualized. And I'm trying to understand the puts and takes. I understand with the neuro and some of the comments and maybe that's not a growth business, but just trying to understand is that -- do you expect that to go back significantly? I'm just trying to put all this together, and it just seems a little lower than what we would have expected.

Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst : And then just a follow-up on that. In terms of the neurovascular, you've talked, I think, last year a bit now this -- some of the commentary in the prepared remarks just the kind of new platform to replace the JET 7 in this neuro area. I was just wondering if we could get a little more color on what those -- the features benefits may be, and if not on that granularity, at least maybe some timing associated we should think about? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 23, 2021 / 9:30PM, PEN.N - Q4 2020 Penumbra Inc Earnings Call

Question: K. Gong - JPMorgan Chase & Co, Research Division - Analyst : This is actually Allen on for Robbie. I want to start off with a quick question on Lightning. Obviously, the peripheral side of the thrombectomy business is going to continue to do very well, even with COVID-19 headwinds. So when we look at Lightning 7 and the kind of growth that Lightning 12 has given you, given it is moving into an area that you already had a very strong presence in arterial, should we think of that as a more kind of like a modest benefit to the business and it's not like you're moving into an area that you didn't have a strong presence in already? Or can we think of that as being as big of an impact as Lightning 12 was for the broader franchise?